Elaine O Petrof Selected Research

Infections

1/2024	Defined microbial communities and their soluble products protect mice from Clostridioides difficile infection.
1/2021	The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial.
1/2016	A Practical Method for Preparation of Fecal Microbiota Transplantation.
1/2013	Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.
12/2012	Probiotics in the critically ill: a systematic review of the randomized trial evidence.
1/2010	Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state.
3/2008	Flagellin is required for salmonella-induced expression of heat shock protein Hsp25 in intestinal epithelium.
6/2004	Bacterial superantigen-treated intestinal epithelial cells upregulate heat shock proteins 25 and 72 and are resistant to oxidant cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elaine O Petrof Research Topics

Disease

9	Clostridium Infections 01/2021 - 01/2013
8	Infections 01/2024 - 06/2004
4	Colitis 01/2016 - 07/2012
4	Necrotizing Enterocolitis 01/2013 - 08/2009
3	Diarrhea 01/2024 - 01/2016
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 07/2015
3	Inflammation (Inflammations) 09/2015 - 11/2012
2	Ulcerative Colitis 11/2016 - 09/2014
2	Obesity 11/2016 - 01/2016
2	Bacterial Infections (Bacterial Infection) 11/2012 - 09/2007
2	Salmonella Infections (Salmonellosis) 11/2012 - 03/2008
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Vomiting 01/2021
1	Nausea 01/2021
1	Reinfection 01/2019
1	Visceral Pain 11/2017
1	Dysbiosis 11/2017
1	Weight Gain 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Weight Loss (Weight Reduction) 11/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2013
1	Critical Illness (Critically Ill) 12/2012
1	Carcinogenesis 11/2012
1	Acidosis 05/2008
1	Reperfusion Injury 03/2007

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2013
2	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2015 - 07/2015
2	Vitamin D FDA LinkGeneric 09/2015 - 07/2015
2	Erythropoietin FDA Link 01/2013 - 04/2011
1	HydrolasesIBA 10/2019
1	Bile Acids and Salts (Bile Acids)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	CytokinesIBA 11/2015
1	Butyrates (Butyrate)IBA 07/2015
1	Dextran SulfateIBA 07/2015
1	Conditioned Culture MediaIBA 01/2013
1	CateninsIBA 11/2012
1	AntigensIBA 01/2010
1	16S Ribosomal RNAIBA 08/2009
1	Caspase 3 (Caspase-3)IBA 05/2008
1	Sodium-Hydrogen ExchangersIBA 05/2008
1	Chloride Channels (Chloride Channel)IBA 05/2008
1	AcidsIBA 05/2008
1	Platelet Activating FactorIBA 05/2008
1	CaspasesIBA 05/2008
1	FlagellinIBA 03/2008
1	NF-kappa B (NF-kB)IBA 09/2007
1	Interleukin-6 (Interleukin 6)IBA 09/2007
1	QuinolonesIBA 03/2007
1	Dynorphins (Dynorphin)IBA 03/2007
1	Bacterial ToxinsIBA 06/2004

Therapy/Procedure

9	Therapeutics 01/2024 - 07/2012
5	Fecal Microbiota Transplantation 01/2020 - 05/2014
1	Transplantation 01/2021
1	Retreatment 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Oral Administration 11/2013
1	Length of Stay 12/2012